This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jay N. Cohn, MD; Thomas S. Rector, PhD

JAMA. 1988;259(23):3456-3457.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Vasodilator therapy has now gained wide acceptance as appropriate adjuvant drug treatment for congestive heart failure. Although this therapy previously was reserved for relief of persistent symptoms in patients who were already taking digitalis and diuretics, recent data have provided support for the concept that use of these drugs may prolong life in addition to relieving symptoms.^1,2 The evidence that systemic . . . [Full Text PDF of this Article]

Author Affiliations
University of Minnesota Medical School Minneapolis

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?